In addition, ibudilast has been shown to alleviate Alzheimer’s disease by reducing the production of inflammatory factors via the downregulation of NF-κB (Wang et al., 2014; Schwenkgrub et al., 2017). Here, NFKB1 is linked to early-onset autosomal dominant Alzheimer disease.